CNBC Television published this video item, entitled “Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion” – below is their description.
Jazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding cannabis-based epilepsy treatment. CNBC’s Jim Cramer and David Faber discuss.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.